Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00973375
Other study ID # LHQ09-003
Secondary ID
Status Recruiting
Phase N/A
First received September 8, 2009
Last updated September 8, 2009
Start date May 2009

Study information

Verified date September 2009
Source Liuhuaqiao Hospital
Contact n/a
Is FDA regulated No
Health authority China: Ethics Committee
Study type Observational

Clinical Trial Summary

The purpose of this study is to investigate if there is any different follow-up results by angiography and IVUS between two different drug-eluting stents after implanted simultaneously in same individuals.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.

Exclusion Criteria:

- Dual anti-platelet therapy less than 12 months.

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
China Liuhuaqiao Hospital Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Liuhuaqiao Hospital

Country where clinical trial is conducted

China, 

References & Publications (3)

Lee CH, Zhang J, Kailasam A, Tai BC, Ye F, Low AF, Hou X, Hay ET, Teo SG, Lim YT, Chen S, Tan HC. An intravascular ultrasound study of Cypher, Taxus, and endeavor stents on relation between neointimal proliferation and residual plaque burden. J Interv Cardiol. 2008 Dec;21(6):519-27. doi: 10.1111/j.1540-8183.2008.00397.x. Epub 2008 Oct 21. — View Citation

Miyazawa A, Ako J, Hongo Y, Hur SH, Tsujino I, Courtney BK, Hassan AH, Kandzari DE, Honda Y, Fitzgerald PJ; ENDEAVOR III Investigators. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III. Am Heart J. 2008 Jan;155(1):108-13. Epub 2007 Sep 14. — View Citation

Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ; ENDEAVOR IV Trial Investigators. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv. 2009 Aug;2(8):779-84. doi: 10.1016/j.jcin.2009.05.015. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Segment and instent restenosis measured by coronary angiography and IVUS. at 12 months after implantation No
Secondary Uncovered and malposition of stent. at 12 months after implantation. Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05477940 - Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System N/A
Not yet recruiting NCT04518826 - A Comparison Between FFR Guided and CAG Guided Treatment Using DEB in ISR of DES
Recruiting NCT03287167 - Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease Phase 4
Completed NCT03859674 - Firehorus Rapamycin Target Eluting Vertebral Artery Stent System in Clinical Application N/A
Completed NCT01239914 - CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)
Completed NCT03622203 - Outcome of CHAllenging lesioNs and Patients Treated With Polymer Free Drug-CoatEd Stent
Recruiting NCT05658250 - CREATE Trial, Prospective, Observational Study
Completed NCT03312296 - Definite Stent Thrombosis in Comatose Out of Hospital Cardiac Arrest Survivors